Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for the Reduction of Thrombo-embolism in Patients with Sub-clinical Atrial Fibrillation
2014-001397-33Phase 4Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of apixaban in Atrial fibrillation (AFib) and cardiac morbidity (2 arms), sponsored by Hamilton Health Sciences. Started Jun 2015; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)cardiac morbidity
Beyond the preview
Go deeper on 2014-001397-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001397-33.